Journal
BIOACTIVE MATERIALS
Volume 6, Issue 4, Pages 963-974Publisher
KEAI PUBLISHING LTD
DOI: 10.1016/j.bioactmat.2020.09.014
Keywords
Hyaluronidase; Exosomes; Tumor microenvironment; Metastasis; Tumor immunotherapy
Funding
- National Key Research and Development Program of China [2017YFB1303100]
- National Natural Science Foundation of China [81773282, 81972630, 81672528, 81874090]
- National Key Scientific Instrument and Equipment Development Project [81927807]
Ask authors/readers for more resources
The novel exosome-based drug delivery system designed in this study effectively degrades high molecular weight hyaluronan and modifies the immune microenvironment, reducing tumor cell metastasis.
High accumulation of hyaluronan (HA) in the tumor microenvironment leads to an increase in the interstitial pressure and reduction perfusion of drugs. Furthermore, high molecular-weight (HMW)-HA suppresses M1 macrophage polarization, enhances M2 polarization, and induces immunosuppression. Hyaluronidase treatment have attempted to decrease the quantity of HA in tumors. However, hyaluronidase-driven HA degradation driven accelerates tumor cell metastasis, which is a major cause of mortality in cancer patients. Thus, we designed a novel exosome-based drug delivery system (DDS), named Exos-PH20-FA, using genetic engineering to express human hyaluronidase (PH20) and self-assembly techniques to modify the exosomes with folic acid (FA). Our results show that Exos-PH20-FA degraded HMW-HA to low-molecular-weight (LMW)-HA. Moreover, LMW-HA polarized macrophages to the M1 phenotype and reduced the number of relevant immunosuppressive immunocytes which changed the immune micmenvironment from an immunosuppressive to immunosupportive phenotype. Furthermore, we demonstrated Exos-PH20-FA directly reduced hyaluronidase-induced metastasis of tumor cells. This tumor treatment also allowed an enhanced delivery of chemotherapy by tumor-targeting effect with FA modification. Our findings indicate that Exos-PH20-FA improves tumor treatment efficiency and reduces the side effects of hyaluronidase treatment, namely tumor cell metastasis. This all-in-one exosome-based HA targeting DDS maybe a promising treatment that yields more efficient and safer results.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available